PTHL (Pheton Holdings Ltd) קצב צמיחת רווח למניה בשנה הנוכחית

Pheton Holdings Ltd focuses on developing software for Chinese radiotherapy, utilizing outsourced production and logistics. The primary driver is the market launch of AI systems for tumor treatment, which is evidenced by a comparable annual growth rate in earnings per share. The current value of the parameter is 0.00, capturing the business efficiency dynamics per security.
פילוחי מדדים פיננסיים ומדדי שוק עבור ftzy.com.cn (PTHL)

Steady demand for medical innovations at Pheton Holdings Ltd (PTHL) minimizes the impact of market cycles on financial results. The annual change in earnings per share reflects the dynamics of net income per share relative to the previous year. This indicator measures the efficiency of commercializing developments and the business's ability to increase profitability. The upward trajectory confirms the successful completion of clinical trials, although extreme peaks may signal an overvaluation of the asset.